ArticleCrohn's & colitis 3602025

Real-World Effectiveness of Risankizumab in Crohn's Disease: Outcome Data for an IL-23 Inhibitor from the Middle East.

Mohamed Nasir Alzaabi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.